AMGN
Amgen Inc. · Healthcare · Drug Manufacturers - General
Señales de momentum (gestores comparables):
amplitud de titulares -5.0% ·
flujo de acciones +0.2% ·
nuevas posiciones netas -5.3%
· fórmula
Acumulación concentrada: acciones en aumento entre menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 1.52M | $603.13M | n/a | n/a |
| Q2 2026 | 169 | -1 | 364.70M | $131.99B | +5 | −7 |
| Q1 2026 | 174 | -2 | 366.40M | $128.82B | +4 | −7 |
| Q4 2025 | 175 | 0 | 394.29M | $128.98B | +2 | −1 |
| Q3 2025 | 26 | 0 | 206.42M | $58.23B | n/a | −1 |
| Q2 2025 | 24 | +1 | 183.25M | $51.15B | +2 | −1 |
| Q1 2025 | 20 | -2 | 81.79M | $25.47B | n/a | −2 |
| Q4 2024 | 22 | +2 | 74.78M | $19.48B | +2 | n/a |
| Q3 2024 | 19 | -1 | 39.65M | $12.76B | +1 | −2 |
| Q2 2024 | 20 | n/a | 39.58M | $12.36B | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | PRIMECAP Management ✦ | 14.26M | -1.3% | $4.59B | 3.4% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasivo) | 12.12M | +0.9% | $3.89B | 0.3% | ▲ Add | 2 | SEC ↗ ×2 |
| 3 | Norges Bank ✦ (pasivo) | 5.80M | -0.1% | $1.87B | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 4.55M | +0.6% | $1.46B | 0.2% | ▲ Add | 2 | SEC ↗ ×2 |
| 5 | Marshall Wace ✦ | 705.11K | +7.4% | $227.19M | 0.3% | ▲ Add | 2 | SEC ↗ ×2 |
| 6 | Adage Capital Partners ✦ | 601.66K | +4.0% | $193.86M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 7 | Capital World Investors ✦ | 466.65K | Nuevo | $150.36M | 0.0% | New | 1 | SEC ↗ |
| 8 | Two Sigma Investments ✦ | 358.74K | -33.8% | $115.59M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 239.35K | +2.1% | $77.12M | 0.0% | ▲ Add | 2 | SEC ↗ ×8 |
| 10 | D. E. Shaw & Co. ✦ | 166.45K | -45.7% | $53.63M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 120.74K | +65.1% | $38.75M | 0.1% | ▲ Add | 2 | SEC ↗ ×3 |
| 12 | Fisher Asset Management ✦ | 102.35K | +21.3% | $32.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | ARK Investment Management ✦ | 76.61K | +2.4% | $24.69M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 14 | Millennium Management ✦ | 30.01K | -55.3% | $9.67M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 21.41K | -3.3% | $6.90M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 16 | Dodge & Cox ✦ | 14.28K | -0.7% | $4.60M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 7.80K | -65.8% | $2.51M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | GAMCO Investors ✦ | 5.25K | -6.2% | $1.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Bridgewater Associates ✦ | 3.37K | -61.4% | $1.09M | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Capital World Investors | $150.36M | 0.0% |
Posición cerrada
| Renaissance Technologies | $16.32M | era 0.0% |
| Arrowstreet Capital | $11.65M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 3,100 tenedores, 420.54M acciones, $144.29B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 1.25K acc. · $521,365
Officer · 2.00K acc. · $825,134
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología